Related Experiment Videos
Mitigation of hyperacute rejection by antilymphocyte globulin (ALG)
Transplantation Proceedings
|March 1, 1979
Summary
Humoral factors, not cellular, drive heart transplant rejection. Antilymphocyte globulin (ALG) temporarily preserves renal blood flow (RBF) but doesn't stop humoral damage, indicating RBF alone is insufficient to assess rejection.
Area of Science:
- Immunology
- Transplantation Medicine
- Nephrology
Background:
- Heart transplant rejection (HR) involves humoral immunologic factors destroying the graft.
- White blood cell (WBC) trapping reduces renal blood flow (RBF), particularly in the renal cortex.
Purpose of the Study:
- To investigate the impact of antilymphocyte globulin (ALG) on HR pathophysiology.
- To determine if RBF measurements accurately reflect HR inhibition.
Main Methods:
- Assessed pathologic and functional criteria over 8 hours.
- Measured total RBF in the context of HR and ALG pretreatment.
Main Results:
- ALG partially suppresses cellular infiltration, delaying RBF cessation.
- ALG does not prevent the progression of humoral factor-mediated graft damage.
- Exclusive measurement of total RBF did not inhibit the course of HR.
Conclusions:
- Humoral factors are the primary drivers of heart transplant rejection.
- RBF monitoring alone is inadequate for evaluating the effectiveness of HR treatments.
- Targeting humoral factors is crucial for preventing graft destruction.